These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 11464473

  • 21. T-cell vaccination in multiple sclerosis.
    Achiron A, Mandel M.
    Autoimmun Rev; 2004 Jan; 3(1):25-32. PubMed ID: 14871646
    [Abstract] [Full Text] [Related]

  • 22. [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].
    Achiron A, Miron S.
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S41-4. PubMed ID: 10896988
    [Abstract] [Full Text] [Related]

  • 23. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H, Skoog B, Hillert J, Runmarker B, Stawiarz L, Oluf A.
    Lakartidningen; 2000 May; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract] [Full Text] [Related]

  • 24. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S, Sorensen PS.
    J Neurol Sci; 2005 Jun 15; 233(1-2):61-5. PubMed ID: 15949496
    [Abstract] [Full Text] [Related]

  • 25. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T, Bereczki D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):401-16. PubMed ID: 15662768
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Multiple sclerosis].
    Ochi H, Kira J.
    Ryoikibetsu Shokogun Shirizu; 2000 Nov 20; (31):47-51. PubMed ID: 11269138
    [No Abstract] [Full Text] [Related]

  • 31. [Contribution of immunology to the treatment of multiple sclerosis].
    Pérez-Miranda J, Parrilla-Ramírez JL.
    Rev Neurol; 1998 Jul 20; 27(155):117-21. PubMed ID: 9674043
    [Abstract] [Full Text] [Related]

  • 32. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K, Reder AT.
    Mult Scler; 2007 May 20; 13(4):459-70. PubMed ID: 17463069
    [Abstract] [Full Text] [Related]

  • 33. T cell vaccination as an immunotherapy for autoimmune diseases.
    Zhang J.
    Cell Mol Immunol; 2004 Oct 20; 1(5):321-7. PubMed ID: 16285890
    [Abstract] [Full Text] [Related]

  • 34. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y, Suárez-Luis I.
    Rev Neurol; 2004 Oct 20; 36(7):649-52. PubMed ID: 12666047
    [Abstract] [Full Text] [Related]

  • 35. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.
    Korporal M, Haas J, Balint B, Fritzsching B, Schwarz A, Moeller S, Fritz B, Suri-Payer E, Wildemann B.
    Arch Neurol; 2008 Nov 20; 65(11):1434-9. PubMed ID: 19001161
    [Abstract] [Full Text] [Related]

  • 36. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G, Caielli S, Cutuli D, Falcone M.
    Immunology; 2007 Nov 20; 122(3):409-17. PubMed ID: 17617156
    [Abstract] [Full Text] [Related]

  • 37. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
    Sarchielli P, Zaffaroni M, Floridi A, Greco L, Candeliere A, Mattioni A, Tenaglia S, Di Filippo M, Calabresi P.
    Mult Scler; 2007 Apr 20; 13(3):313-31. PubMed ID: 17439900
    [Abstract] [Full Text] [Related]

  • 38. Intensive immunosuppression in multiple sclerosis.
    Zaffaroni M, Ghezzi A, Comi G.
    Neurol Sci; 2006 Mar 20; 27 Suppl 1():S13-7. PubMed ID: 16708175
    [Abstract] [Full Text] [Related]

  • 39. The immunological basis for treatment of multiple sclerosis.
    Holmøy T, Vartdal F.
    Scand J Immunol; 2007 Oct 20; 66(4):374-82. PubMed ID: 17850581
    [Abstract] [Full Text] [Related]

  • 40. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
    MMW Fortschr Med; 2008 Apr 10; 150(15):17. PubMed ID: 18510111
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.